POSTMENOPAUSAL OSTEOPOROSIS
Clinical trials for POSTMENOPAUSAL OSTEOPOROSIS explained in plain language.
Never miss a new study
Get alerted when new POSTMENOPAUSAL OSTEOPOROSIS trials appear
Sign up with your email to follow new studies for POSTMENOPAUSAL OSTEOPOROSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Which drug best prevents bone loss after stopping osteoporosis treatment?
Disease control Not yet recruitingThis study tests whether a bone-strengthening drug called ibandronate works as well as another drug, zoledronic acid, to prevent bone loss in postmenopausal women who have stopped taking denosumab. About 52 women aged 50-85 with osteoporosis or low bone density will receive one o…
Matched conditions: POSTMENOPAUSAL OSTEOPOROSIS
Phase: PHASE4 • Sponsor: National Taiwan University Hospital • Aim: Disease control
Last updated Apr 29, 2026 15:04 UTC
-
Hidden body chemical may explain why some osteoporosis drugs fail
Knowledge-focused Not yet recruitingThis study will follow 240 women with osteoporosis to see if a substance called AGE that builds up in the body over time affects how well bone-strengthening medications work. Researchers will measure AGE levels using a simple skin light test and track changes in bone density and …
Matched conditions: POSTMENOPAUSAL OSTEOPOROSIS
Sponsor: Bursa City Hospital • Aim: Knowledge-focused
Last updated Apr 30, 2026 15:52 UTC